Cargando…
Upregulation of Galectin-9 and PD-L1 Immune Checkpoints Molecules in Patients with Chronic Lymphocytic Leukemia
BACKGROUND: Deviation of host immune response by engagement of inhibitory receptors is one of the well-known mechanisms of tumor cells for immune evasion and survival. PD-1/PD-L1 and Tim-3/Gal-9 axes are two major pathways in this area which their contribution has been documented in a variety of mal...
Autores principales: | Taghiloo, Saeid, Allahmoradi, Esmaeil, Ebadi, Reza, Tehrani, Mohsen, Hosseini-Khah, Zahra, Janbabaei, Ghasem, Shekarriz, Ramin, Asgarian-Omran, Hossein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697491/ https://www.ncbi.nlm.nih.gov/pubmed/28843266 http://dx.doi.org/10.22034/APJCP.2017.18.8.2269 |
Ejemplares similares
-
Combined Blockade Of PD-1 and TIGIT is not Sufficient to Improve the Function Of CD8+ T-Cells in Chronic Lymphocytic Leukemia
por: Hatefi, Fatemeh, et al.
Publicado: (2022) -
Anti-inflammatory effects of the Portulaca oleracea hydroalcholic extract on human peripheral blood mononuclear cells
por: Allahmoradi, Esmaeil, et al.
Publicado: (2018) -
Expression Modulation of Immune Checkpoint Molecules by Ibrutinib and Everolimus Through STAT3 in MCF-7 Breast Cancer Cells
por: Soltanshahi, Mohsen, et al.
Publicado: (2022) -
Expression Analysis of Fyn and Bat3 Signal Transduction Molecules in Patients with Chronic Lymphocytic Leukemia
por: Hosseini-Valiki, Fereshteh, et al.
Publicado: (2020) -
Relative Expression of BATF and CD112 in PBMC of Patients with Chronic Lymphocytic Leukemia
por: Najafi, Ahmad, et al.
Publicado: (2023)